Nvidia
NVDA on Nasdaq. NVIDIA sells chips and software to companies building AI systems. Market value $5.8tn.
Price checks use the past 12 months to July 2026. Quality checks use five annual reports, the latest for the year to January 2026.
Should I look at this?
Good business, but not cheap right now
Why it could be worth it
See cheaper Technology stocks on the list
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $2.21 of spare cash in the past 12 months. A savings account pays about $4.
You pay 29.2 years of operating profit for the business. The average large US company costs around 18.
Each dollar kept in the business earns 57 cents a year. Above 10 is good.
Quality score: 100 of 100. Price score: 32 of 100. Our list needs 70 on quality and 60 on price.
$238.90 a share, 45% above its 1-year low
Over the past year the price has ranged from $164.27 to $240.10.
Dividend: 0.0% a year
Paid every year for at least 5 years
Payouts have jumped around in recent years, so this may not repeat.
Prices from Monday’s close (5 October).
Five years of cash, in billions
| Revenue | |||||
| Revenue | $26.9bn | $27.0bn | $60.9bn | $130.5bn | $215.9bn |
| Operating margin | |||||
| Operating margin | 37.3% | 15.7% | 54.1% | 62.4% | 60.4% |
| Debt to equity | |||||
| Debt to equity | 0.41 | 0.50 | 0.23 | 0.11 | 0.05 |
| Shares outstanding | |||||
| Shares outstanding | 2.47bn | 2.50bn | 24.40bn | 24.30bn | 24.10bn |
Health checks
- Free cash flow positive5 of 5 years
- Accounting looks honest (Beneish)Warning signs
- Financial strength (Piotroski)4 of 9
- Profit backed by cash (accruals)No
- Debt0.05× equity
- Revenue growth, five yearsStrong, 67.2% a year
- Buying back its own sharesNo, 876% more shares since 2022
The quarter to July 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $96.2 billion last quarter, up 106% on a year ago.
- Profit: $59.7 billion, up 126% on a year ago.
- It keeps 65 cents of each $1 of sales as operating profit, up from 58 cents a year earlier.
- Spare cash over the past 12 months: $127 billion, up from $72 billion.
- 1% fewer shares than a year ago. Each share owns a bit more of the company.
- Debt is $10.9 billion more than cash. A year ago it had $3.2 billion more cash than debt.
- Sales grew on a year ago in each of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| October 2024 | $35.1bn |
| January 2025 | $39.3bn |
| April 2025 | $44.1bn |
| July 2025 | $46.7bn |
| October 2025 | $57.0bn |
| January 2026 | $68.1bn |
| April 2026 | $81.6bn |
| July 2026 | $96.2bn |
| Quarter to | Amount |
|---|---|
| October 2024 | $19.3bn |
| January 2025 | $22.1bn |
| April 2025 | $18.8bn |
| July 2025 | $26.4bn |
| October 2025 | $31.9bn |
| January 2026 | $43.0bn |
| April 2026 | $58.3bn |
| July 2026 | $59.7bn |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- 17 November 2026
- Last annual report (10-K)
- 25 February 2026
- Next quarterly (estimated, 10-Q)
- 25 November 2026
Who owns it
36 long-term investors we follow own it, unchanged from 36 last quarter. 5,957 funds in all.
- Mairs & PowerAndy Adams
- Value
- $942m
- Share of fund
- 8.6%
- First Manhattan Co.First Manhattan partners
- Value
- $507m
- Share of fund
- 1.3%
- Patient Capital ManagementSamantha McLemore
- Value
- $142m
- Share of fund
- 4.7%
- Weitz Investment ManagementWally Weitz
- Value
- $7m
- Share of fund
- 0.5%
- Platinum Investment ManagementPlatinum team
- Value
- $6m
- Share of fund
- 1.4%
- Corvex ManagementKeith Meister
- Value
- $3m
- Share of fund
- 0.1%
- Harris Associates (Oakmark)Bill Nygren
- Value
- $2m
- Share of fund
- <0.1%
- Horizon KineticsMurray Stahl
- Value
- $1m
- Share of fund
- <0.1%
- Causeway Capital ManagementSarah Ketterer
- Value
- $713,721
- Share of fund
- <0.1%
- Dodge & CoxDodge & Cox investment committee
- Value
- $680,306
- Share of fund
- <0.1%
- Auxier Asset ManagementJeff Auxier
- Value
- $624,481
- Share of fund
- <0.1%
- Heartland AdvisorsBill Nasgovitz
- Value
- $266,120
- Share of fund
- <0.1%
- Beutel GoodmanBeutel Goodman team
- Value
- $26,000
- Share of fund
- <0.1%
Sold out this quarter
- Third PointDan LoebSold out
Largest holders overall
- BlackRock$388.6bn
- Vanguard Capital Management$308.3bn
- FMR$205.3bnAdded
- State Street$202.0bn
- Geode Capital Management$121.0bn
- Vanguard Portfolio Management$103.6bn
- JPMorgan Chase$87.6bn
- Price T Rowe Associates$74.0bn
- Morgan Stanley$71.3bnAdded
- Invesco$65.9bn
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
1 investor owns more than 5%.
- Vanguard Capital ManagementPassive investor7.3%Since 31 March 2026
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
Vanguard Capital Management Passive investor | 7.3% | 31 March 2026 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 12 sold $2.1bn, $563m of it under preset trading plans.
- Teter Timothy S.EVP, General Counsel and SecSoldunder a preset trading plan
- Date
- 21 September 2026
- Shares
- 30,460
- Price
- $222.80
- Value
- $7m
- STEVENS MARK ADirectorSold
- Date
- 18 September 2026
- Shares
- 1,366,000
- Price
- $219.73
- Value
- $300m
- Kress ColetteEVP & Chief Financial OfficerSoldunder a preset trading plan
- Date
- 17 September 2026
- Shares
- 34,918
- Price
- $219.05
- Value
- $8m
- STEVENS MARK ADirectorSold
- Date
- 4 September 2026
- Shares
- 622,239
- Price
- $231.62
- Value
- $144m
- STEVENS MARK ADirectorSold
- Date
- 3 September 2026
- Shares
- 400,000
- Price
- $228.78
- Value
- $92m
- STEVENS MARK ADirectorSold
- Date
- 2 September 2026
- Shares
- 1,200,000
- Price
- $223.33
- Value
- $268m
- STEVENS MARK ADirectorSold
- Date
- 1 September 2026
- Shares
- 63,501
- Price
- $220.06
- Value
- $14m
- Teter Timothy S.EVP, General Counsel and SecSoldunder a preset trading plan
- Date
- 31 August 2026
- Shares
- 30,000
- Price
- $217.88
- Value
- $7m
- STEVENS MARK ADirectorSold
- Date
- 31 August 2026
- Shares
- 585,000
- Price
- $220.29
- Value
- $129m
- STEVENS MARK ADirectorSold
- Date
- 18 June 2026
- Shares
- 885,000
- Price
- $210.17
- Value
- $186m
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 21 September 2026 | Teter Timothy S. EVP, General Counsel and Sec | Sold under a preset trading plan | 30,460 | $222.80 | $7m |
| 18 September 2026 | STEVENS MARK A Director | Sold | 1,366,000 | $219.73 | $300m |
| 17 September 2026 | Kress Colette EVP & Chief Financial Officer | Sold under a preset trading plan | 34,918 | $219.05 | $8m |
| 4 September 2026 | STEVENS MARK A Director | Sold | 622,239 | $231.62 | $144m |
| 3 September 2026 | STEVENS MARK A Director | Sold | 400,000 | $228.78 | $92m |
| 2 September 2026 | STEVENS MARK A Director | Sold | 1,200,000 | $223.33 | $268m |
| 1 September 2026 | STEVENS MARK A Director | Sold | 63,501 | $220.06 | $14m |
| 31 August 2026 | Teter Timothy S. EVP, General Counsel and Sec | Sold under a preset trading plan | 30,000 | $217.88 | $7m |
| 31 August 2026 | STEVENS MARK A Director | Sold | 585,000 | $220.29 | $129m |
| 18 June 2026 | STEVENS MARK A Director | Sold | 885,000 | $210.17 | $186m |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the warning signs we check for were found.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 25 Feb 2026, plus the 10-Q filed 26 Aug 2026 and 10 later 8-Ks.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
- Its accounts show patterns that sometimes come before companies have to correct past results (Beneish score).
- Profits run ahead of cash.
- It isn't cheap on profits: 29.2× operating profit.
Whether the price already reflects the risks is what the deep dive is for.
What changed in the risks this year
Companies must list what could hurt them each year. These are the parts that changed since last year’s report.
Failure to meet the evolving needs of our industry and markets may adversely impact our financial results.
Could happenWe have entered into an intellectual property license arrangement with Groq, Inc., or Groq, that required significant, nonrefundable payments. Successfully incorporating the licensed technology into our architectures and product roadmaps requires significant engineering effort and may not occur on expected timelines or at all. The licensed technology may not achieve the desired results as designed or achieve customer or ecosystem adoption. The economic outcomes of this arrangement depend on our ability to translate the licensed technology into commercially viable products and services over time, and we may be unable to recover the associated costs or realize an adequate return on this spend. If our efforts to use the licensed technology are delayed or unsuccessful, our business, operating results, and financial condition could be negatively impacted.
Read moreWe may not be able to realize the potential benefits of business investments or acquisitions, and we may not be able to successfully integrate acquired companies, which could hurt our ability to grow our business, develop new products or sell our products.
Could happenWe are finalizing an investment and partnership agreement with OpenAI. There is no assurance that we will enter into an investment and partnership agreement with OpenAI or that a transaction will be completed.
We are subject to complex laws, rules, regulations, and political and other actions, including restrictions on the export of our products, which may adversely impact our business.
Could happenIn May 2025, the USG announced that it would rescind the AI Diffusion IFR and implement a replacement rule. The scope, timing, and requirements of the forthcoming rule remain uncertain. The replacement rule may impose new restrictions on our products or operations and/or add license requirements that could have a material impact on our business, operating results, and financial condition. For example, in October 2025, the Senate passed the “GAIN AI Act” in the NDAA. The GAIN AI Act would restrict the Trump Administration’s ability to adapt the Biden Administration’s export control rules, and could also allow private U.S. persons to review and overturn licensing and foreign policy decisions made by the Trump Administration.
Read moreWe are subject to complex laws, rules, regulations, and political and other actions, including restrictions on the export of our products, which may adversely impact our business.
Already happenedIn April 2025, the USG informed us that it requires a license for export to China (including Hong Kong and Macau) and D:5 countries, or to companies headquartered or with an ultimate parent therein, of our H20 integrated circuits and any other circuits achieving the H20’s memory bandwidth, interconnect bandwidth, or combination thereof. As a result of these requirements, we incurred a $4.5 billion charge in the first quarter of fiscal year 2026 associated with H20 for excess inventory and purchase obligations, as the demand for H20 products diminished.
Read moreCommercial arrangements expose us to counterparty risks.
Could happenWe have entered and may in the future enter into commercial arrangements, including long-term capacity purchase obligations and financial guarantees, and have been asked to offer financing arrangements to support our customers’ and partners’ buildout of datacenter infrastructure. We have not entered into any financing arrangements. Commercial arrangements expose us to counterparty risk, including customers' or partners' inability to fulfill their financial commitments and secure necessary financing or infrastructure, the occurrence of significant project delays, and counterparty financial distress or insolvency, all of which may negatively impact our business, financial condition, or results of operations. Financing arrangements, if undertaken, may in some circumstances result in lower upfront cash flows associated with extended payment terms or payment terms made over a multi-year term and may increase credit risk.
Read more
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.